+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Pneumococcal Vaccine Market by Type (Conjugate Vaccines, Polysaccharide Vaccines), Indication (Bronchitis, Meningitis, Pneumonia), Age Group, Distribution - Forecast 2024-2030- Product Image
Global Pneumococcal Vaccine Market by Type (Conjugate Vaccines, Polysaccharide Vaccines), Indication (Bronchitis, Meningitis, Pneumonia), Age Group, Distribution - Forecast 2024-2030- Product Image
Sale

Global Pneumococcal Vaccine Market by Type (Conjugate Vaccines, Polysaccharide Vaccines), Indication (Bronchitis, Meningitis, Pneumonia), Age Group, Distribution - Forecast 2024-2030

  • PDF Icon

    Report

  • 197 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 4968848
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Pneumococcal Vaccine Market size was estimated at USD 10.73 billion in 2023, USD 11.56 billion in 2024, and is expected to grow at a CAGR of 7.92% to reach USD 18.30 billion by 2030.

The pneumococcal vaccine is designed to protect against infections caused by the streptococcus pneumoniae bacteria. These infections range from ear and sinus infections to more severe illnesses, including pneumonia, meningitis, and bloodstream infections. The vaccine is essential for children, the elderly, and individuals with certain health conditions that make them more vulnerable to disease. With the increasing prevalence of pneumococcal diseases as global populations age and more individuals are at risk of chronic diseases, there is an increased need for pneumococcal vaccines. The availability of support from governments and international health organizations for pneumococcal vaccines is driving the market growth.

These vaccines are often included in national immunization schedules to reduce the incidence of bacterial infections, especially in children and the elderly. Growing awareness about the importance of immunizations, bolstered by public health campaigns and education programs, supports the growth of the pneumococcal vaccine market. The high development cost and complex vaccine storage and handling requirements hamper the market growth. Rising improvements in vaccine technology and the development of conjugate vaccines that provide broader protection against various strains of bacteria are expected to create opportunities for the pneumococcal vaccine market.

Regional Insights

America shows a highly developing pneumococcal vaccine market with well-structured healthcare systems and high awareness regarding vaccination protocols, including pneumococcal vaccination, especially for infants and the elderly segment of the population. Policy initiatives, including immunization programs integrated into public health policy, further stimulate vaccine coverage. In APAC, the market dynamics vary widely across countries due to differences in economic development, healthcare infrastructure, and government policies related to vaccinations.

Countries such as Japan, Australia, and South Korea exhibit higher adoption rates for pneumococcal vaccines, driven by favorable healthcare policies and a rising awareness of preventive healthcare. Meanwhile, emerging economies such as India, Japan, and China are experiencing rapid growth in vaccine uptake due to improving healthcare infrastructure, increasing middle-class populations, and government immunization drives against pneumococcal diseases. Europe is a strong market for pneumococcal vaccines, supported by comprehensive healthcare systems and wide vaccine coverage. The Middle East and Africa show varied vaccine adoption rates due to contrasting healthcare capabilities and varying levels of government support for immunization programs. Western European countries generally report higher vaccination rates compared to Eastern European nations. Meanwhile, in Africa and some parts of the Middle East, efforts are ongoing to enhance vaccine access and inoculation rates, often supported by international health organizations.

Market Trends by Segment

  • Type: Growing usage of conjugate vaccines to produce a strong immune response that includes a memory response
  • Distribution: Growing availability of pneumococcal vaccine through government authorities for enhancing vaccination coverage among at-risk populations

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

FDA Approves Merck's New Pneumococcal Vaccine Targeting Broad Protection

The U.S. Food and Drug Administration (FDA) approved Merck's innovative 21-valent pneumococcal conjugate pneumococcal vaccine, designed to offer protection against a comprehensive range of pneumococcal disease strains. This approval underscores a significant advancement in public health, promising enhanced protection for individuals, especially vulnerable populations such as older people and those with compromised immune systems. Merck's vaccine, which has demonstrated efficacy in preventing infections caused by numerous strains of pneumococcal bacteria, aims to reduce the incidence and severity of pneumococcal diseases such as pneumonia, meningitis, and bloodstream infections.

Vaxcyte Bolsters Global Supply Chain with Enhanced Lonza Collaboration for Pneumococcal Vaccine Production

Vaxcyte, Inc. is expanding its collaboration with Lonza, a key global player in the pharmaceutical and biotech manufacturing sector, to elevate the production of VAX-24, its 24-valent pneumococcal conjugate vaccine candidate. This strategic partnership aims to reinforce Vaxcyte's manufacturing capabilities to meet global commercial demands, anticipating the transition into the pivotal Phase 3 vaccine trial. This collaboration underscores both companies' commitment to addressing the wide-ranging pneumococcal disease threat with a next-generation vaccine that could significantly impact public health worldwide.

FDA Approves Pfizer's Prevnar 20 a Significant Advancement in Pneumococcal Disease Prevention

The U.S. Food and Drug Administration (FDA) has recently approved Prevnar 20, a novel 20-valent pneumococcal conjugate vaccine developed by Pfizer. This approval marks a significant milestone in preventing pneumococcal diseases, as Prevnar 20 is designed to protect against twenty pneumococcal serotypes responsible for most pneumococcal disease cases and pneumonia. The vaccine is authorized for use in adults aged 18 years and older, offering enhanced coverage and aiming to improve public health outcomes by reducing the incidences of these severe infections. This development is particularly timely, considering the substantial health burden pneumococcal diseases place on individuals and healthcare systems globally.

Key Company Profiles

The report delves into recent significant developments in the Pneumococcal Vaccine Market, highlighting leading vendors and their innovative profiles. These include AstraZeneca PLC, Biological E. Limited, Biovac, CSL Limited, F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Incepta Pharmaceuticals Ltd., Lonza AG, Merck & Co., Inc., Panacea Biotec Limited, Pfizer, Inc., Sanofi SA, Serum Institute of India Pvt. Ltd., Vaxcyte Inc., and Walvax Biotechnology Co., Ltd.

This research report offers invaluable insights into various crucial aspects of the Pneumococcal Vaccine Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of pneumococcal diseases
5.1.1.2. Rising awareness programs regarding the use of pneumococcal vaccination
5.1.2. Restraints
5.1.2.1. High cost associated with the development of pneumococcal vaccines
5.1.3. Opportunities
5.1.3.1. Introduction of novel pneumococcal vaccines for broader protection against various bacteria strains
5.1.3.2. Improving cold chain networks and growing development of novel delivery systems
5.1.4. Challenges
5.1.4.1. Slow processing of clinical trials for the production of vaccine
5.2. Market Segmentation Analysis
5.2.1. Type: Growing usage of conjugate vaccines to produce a strong immune response that includes a memory response
5.2.2. Distribution: Growing availability of pneumococcal vaccine through government authorities for enhancing vaccination coverage among at-risk populations
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Pneumococcal Vaccine Market, by Type
6.1. Introduction
6.2. Conjugate Vaccines
6.3. Polysaccharide Vaccines
7. Pneumococcal Vaccine Market, by Indication
7.1. Introduction
7.2. Bronchitis
7.3. Meningitis
7.4. Pneumonia
7.5. Sepsis
8. Pneumococcal Vaccine Market, by Age Group
8.1. Introduction
8.2. Adults
8.3. Infants & Young Children
9. Pneumococcal Vaccine Market, by Distribution
9.1. Introduction
9.2. Government Authorities
9.3. Non-Governmental Organizations
10. Americas Pneumococcal Vaccine Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Pneumococcal Vaccine Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Pneumococcal Vaccine Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. FDA Approves Merck's New Pneumococcal Vaccine Targeting Broad Protection
13.3.2. Vaxcyte Bolsters Global Supply Chain with Enhanced Lonza Collaboration for Pneumococcal Vaccine Production
13.3.3. FDA Approves Pfizer's Prevnar 20 a Significant Advancement in Pneumococcal Disease Prevention
13.4. Strategy Analysis & Recommendation
14. Competitive Portfolio
14.1. Key Company Profiles
14.2. Key Product Portfolio
List of Figures
FIGURE 1. PNEUMOCOCCAL VACCINE MARKET RESEARCH PROCESS
FIGURE 2. PNEUMOCOCCAL VACCINE MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. PNEUMOCOCCAL VACCINE MARKET DYNAMICS
FIGURE 7. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 10. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
FIGURE 12. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
FIGURE 14. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. PNEUMOCOCCAL VACCINE MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 24. PNEUMOCOCCAL VACCINE MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. PNEUMOCOCCAL VACCINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINES, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINES, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY POLYSACCHARIDE VACCINES, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY POLYSACCHARIDE VACCINES, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY BRONCHITIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY BRONCHITIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY MENINGITIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY MENINGITIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY PNEUMONIA, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY PNEUMONIA, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY SEPSIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY SEPSIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY ADULTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY ADULTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY INFANTS & YOUNG CHILDREN, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY INFANTS & YOUNG CHILDREN, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY GOVERNMENT AUTHORITIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY GOVERNMENT AUTHORITIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY NON-GOVERNMENTAL ORGANIZATIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY NON-GOVERNMENTAL ORGANIZATIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 36. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 37. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 38. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 39. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 40. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 41. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 42. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 43. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 44. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 45. ARGENTINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 46. ARGENTINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 47. ARGENTINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 48. ARGENTINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 49. ARGENTINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 50. ARGENTINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 51. ARGENTINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 52. ARGENTINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 53. BRAZIL PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 54. BRAZIL PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 55. BRAZIL PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 56. BRAZIL PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 57. BRAZIL PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 58. BRAZIL PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 59. BRAZIL PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 60. BRAZIL PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 61. CANADA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 62. CANADA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 63. CANADA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 64. CANADA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 65. CANADA PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 66. CANADA PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 67. CANADA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 68. CANADA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 69. MEXICO PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 70. MEXICO PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 71. MEXICO PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 72. MEXICO PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 73. MEXICO PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 74. MEXICO PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 75. MEXICO PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 76. MEXICO PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 77. UNITED STATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 78. UNITED STATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 79. UNITED STATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 80. UNITED STATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 81. UNITED STATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 82. UNITED STATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 83. UNITED STATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 84. UNITED STATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 85. UNITED STATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 86. UNITED STATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 87. ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 88. ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 89. ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 90. ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 91. ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 92. ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 93. ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 94. ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 95. ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 96. ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 97. AUSTRALIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 98. AUSTRALIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 99. AUSTRALIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 100. AUSTRALIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 101. AUSTRALIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 102. AUSTRALIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 103. AUSTRALIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 104. AUSTRALIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 105. CHINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 106. CHINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 107. CHINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 108. CHINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 109. CHINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 110. CHINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 111. CHINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 112. CHINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 113. INDIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 114. INDIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 115. INDIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 116. INDIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 117. INDIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 118. INDIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 119. INDIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 120. INDIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 121. INDONESIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 122. INDONESIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 123. INDONESIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 124. INDONESIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 125. INDONESIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 126. INDONESIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 127. INDONESIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 128. INDONESIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 129. JAPAN PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 130. JAPAN PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 131. JAPAN PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 132. JAPAN PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 133. JAPAN PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 134. JAPAN PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 135. JAPAN PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 136. JAPAN PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 137. MALAYSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 138. MALAYSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 139. MALAYSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 140. MALAYSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 141. MALAYSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 142. MALAYSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 143. MALAYSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 144. MALAYSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 145. PHILIPPINES PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 146. PHILIPPINES PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 147. PHILIPPINES PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 148. PHILIPPINES PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 149. PHILIPPINES PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 150. PHILIPPINES PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 151. PHILIPPINES PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 152. PHILIPPINES PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 153. SINGAPORE PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 154. SINGAPORE PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 155. SINGAPORE PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 156. SINGAPORE PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 157. SINGAPORE PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 158. SINGAPORE PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 159. SINGAPORE PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 160. SINGAPORE PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 161. SOUTH KOREA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 162. SOUTH KOREA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 163. SOUTH KOREA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 164. SOUTH KOREA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 165. SOUTH KOREA PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 166. SOUTH KOREA PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 167. SOUTH KOREA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 168. SOUTH KOREA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 169. TAIWAN PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 170. TAIWAN PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 171. TAIWAN PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 172. TAIWAN PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 173. TAIWAN PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 174. TAIWAN PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 175. TAIWAN PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 176. TAIWAN PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 177. THAILAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 178. THAILAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 179. THAILAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 180. THAILAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 181. THAILAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 182. THAILAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 183. THAILAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 184. THAILAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 185. VIETNAM PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 186. VIETNAM PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 187. VIETNAM PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 188. VIETNAM PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 189. VIETNAM PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 190. VIETNAM PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 191. VIETNAM PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 192. VIETNAM PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 203. DENMARK PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 204. DENMARK PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 205. DENMARK PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 206. DENMARK PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 207. DENMARK PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 208. DENMARK PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 209. DENMARK PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 210. DENMARK PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 211. EGYPT PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 212. EGYPT PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 213. EGYPT PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 214. EGYPT PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 215. EGYPT PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 216. EGYPT PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 217. EGYPT PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 218. EGYPT PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 219. FINLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 220. FINLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 221. FINLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 222. FINLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 223. FINLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 224. FINLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 225. FINLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 226. FINLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 227. FRANCE PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 228. FRANCE PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 229. FRANCE PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 230. FRANCE PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 231. FRANCE PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 232. FRANCE PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 233. FRANCE PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 234. FRANCE PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 235. GERMANY PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 236. GERMANY PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 237. GERMANY PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 238. GERMANY PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 239. GERMANY PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 240. GERMANY PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 241. GERMANY PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 242. GERMANY PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 243. ISRAEL PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 244. ISRAEL PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 245. ISRAEL PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 246. ISRAEL PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 247. ISRAEL PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 248. ISRAEL PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 249. ISRAEL PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 250. ISRAEL PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 251. ITALY PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 252. ITALY PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 253. ITALY PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 254. ITALY PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 255. ITALY PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 256. ITALY PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 257. ITALY PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 258. ITALY PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 259. NETHERLANDS PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 260. NETHERLANDS PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 261. NETHERLANDS PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 262. NETHERLANDS PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 263. NETHERLANDS PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 264. NETHERLANDS PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 265. NETHERLANDS PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 266. NETHERLANDS PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 267. NIGERIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 268. NIGERIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 269. NIGERIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 270. NIGERIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 271. NIGERIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 272. NIGERIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 273. NIGERIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 274. NIGERIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 275. NORWAY PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 276. NORWAY PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 277. NORWAY PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 278. NORWAY PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 279. NORWAY PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 280. NORWAY PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 281. NORWAY PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 282. NORWAY PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 283. POLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 284. POLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 285. POLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 286. POLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 287. POLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 288. POLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 289. POLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 290. POLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 291. QATAR PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 292. QATAR PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 293. QATAR PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 294. QATAR PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 295. QATAR PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 296. QATAR PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 297. QATAR PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 298. QATAR PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 299. RUSSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 300. RUSSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 301. RUSSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 302. RUSSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 303. RUSSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 304. RUSSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 305. RUSSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 306. RUSSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 308. SAUDI ARABIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 310. SAUDI ARABIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 312. SAUDI ARABIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 313. SAUDI ARABIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 314. SAUDI ARABIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 315. SOUTH AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 316. SOUTH AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 318. SOUTH AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 320. SOUTH AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 322. SOUTH AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 323. SPAIN PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 324. SPAIN PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 325. SPAIN PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 326. SPAIN PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 327. SPAIN PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 328. SPAIN PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 329. SPAIN PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 330. SPAIN PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 331. SWEDEN PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 332. SWEDEN PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 333. SWEDEN PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 334. SWEDEN PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 335. SWEDEN PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 336. SWEDEN PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 337. SWEDEN PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 338. SWEDEN PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 339. SWITZERLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 340. SWITZERLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 341. SWITZERLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 342. SWITZERLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 343. SWITZERLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 344. SWITZERLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 345. SWITZERLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 346. SWITZERLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 347. TURKEY PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 348. TURKEY PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 349. TURKEY PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 350. TURKEY PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 351. TURKEY PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 352. TURKEY PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 353. TURKEY PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 354. TURKEY PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 355. UNITED ARAB EMIRATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 356. UNI

Companies Mentioned

  • AstraZeneca PLC
  • Biological E. Limited
  • Biovac
  • CSL Limited
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline plc
  • Incepta Pharmaceuticals Ltd.
  • Lonza AG
  • Merck & Co., Inc.
  • Panacea Biotec Limited
  • Pfizer, Inc.
  • Sanofi SA
  • Serum Institute of India Pvt. Ltd.
  • Vaxcyte Inc.
  • Walvax Biotechnology Co., Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages197
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 11.56 Billion
Forecasted Market Value ( USD ) by 2030 $ 18.3 Billion
Compound Annual Growth Rate7.9%
Regions CoveredGlobal
No. of Companies Mentioned15

Related Topics

Related Reports

Pneumococcal Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 - Product Image

Pneumococcal Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

  • Report
  • 178 Pages
  • Global
From
Pneumococcal Vaccines Market : Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030 - Product Image

Pneumococcal Vaccines Market : Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030

  • Report
  • 180 Pages
  • Global
From
Pneumococcal Vaccine Global Market Report 2024 - Product Image

Pneumococcal Vaccine Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Pneumococcal Vaccine Market Report and Forecast 2024-2032 - Product Image

Pneumococcal Vaccine Market Report and Forecast 2024-2032

  • Report
  • 160 Pages
  • Global
From
Pneumococcal Vaccine Market Report by Vaccine Type, Product Type, Distribution Channel, End User, and Region 2023-2028 - Product Image

Pneumococcal Vaccine Market Report by Vaccine Type, Product Type, Distribution Channel, End User, and Region 2023-2028

  • Report
  • 146 Pages
  • Global
From

About the Pneumococcal Vaccine Market

The Pneumococcal Vaccine is a type of vaccine used to protect against infection caused by the bacterium Streptococcus pneumoniae. It is used to prevent a range of illnesses, including pneumonia, meningitis, and sepsis. The vaccine is typically administered to infants and young children, as well as adults who are at an increased risk of infection. It is also recommended for adults over the age of 65. The Pneumococcal Vaccine market is a subset of the larger Vaccines market. It is a highly competitive market, with a number of companies offering different types of vaccines. These companies are typically involved in the research, development, and production of the vaccines. They also provide support services such as distribution, marketing, and education. Some of the companies in the Pneumococcal Vaccine market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and Novartis. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.